| 5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents R Ottana, R Maccari, ML Barreca, G Bruno, A Rotondo, A Rossi, ... Bioorganic & medicinal chemistry 13 (13), 4243-4252, 2005 | 450 | 2005 |
| Discovery of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV-1 agents ML Barreca, A Chimirri, L De Luca, AM Monforte, P Monforte, A Rao, ... Bioorganic & medicinal chemistry letters 11 (13), 1793-1796, 2001 | 362 | 2001 |
| Design, synthesis, structure− activity relationships, and molecular modeling studies of 2, 3-diaryl-1, 3-thiazolidin-4-ones as potent anti-HIV agents ML Barreca, J Balzarini, A Chimirri, ED Clercq, LD Luca, HD Höltje, ... Journal of medicinal chemistry 45 (24), 5410-5413, 2002 | 267 | 2002 |
| Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors ML Barreca, S Ferro, A Rao, L De Luca, M Zappalà, AM Monforte, ... Journal of medicinal chemistry 48 (22), 7084-7088, 2005 | 195 | 2005 |
| A 1, 8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication S Massari, D Daelemans, ML Barreca, A Knezevich, S Sabatini, ... Journal of medicinal chemistry 53 (2), 641-648, 2010 | 169 | 2010 |
| Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 … M Billamboz, F Bailly, ML Barreca, L De Luca, JF Mouscadet, C Calmels, ... Journal of medicinal chemistry 51 (24), 7717-7730, 2008 | 152 | 2008 |
| Pharmacophore‐based discovery of small‐molecule inhibitors of protein–protein interactions between HIV‐1 integrase and cellular cofactor LEDGF/p75 L De Luca, ML Barreca, S Ferro, F Christ, N Iraci, R Gitto, AM Monforte, ... ChemMedChem 4 (8), 1311-1316, 2009 | 139 | 2009 |
| Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance ML Barreca, KW Lee, A Chimirri, JM Briggs Biophysical Journal 84 (3), 1450-1463, 2003 | 106 | 2003 |
| Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist R Gitto, ML Barreca, L De Luca, G De Sarro, G Ferreri, S Quartarone, ... Journal of medicinal chemistry 46 (1), 197-200, 2003 | 103 | 2003 |
| Anti-HIV agents: design and discovery of new potent RT inhibitors ML Barreca, A Chimirri, E De Clercq, L De Luca, AM Monforte, P Monforte, ... Il Farmaco 58 (3), 259-263, 2003 | 93 | 2003 |
| Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains ML Barreca, A Rao, L De Luca, N Iraci, AM Monforte, G Maga, ... Bioorganic & medicinal chemistry letters 17 (7), 1956-1960, 2007 | 92 | 2007 |
| AMPA receptor antagonists as potential anticonvulsant drugs GD Sarro, R Gitto, E Russo, GF Ibbadu, ML Barreca, LD Luca, A Chimirri Current topics in medicinal chemistry 5 (1), 31-42, 2005 | 89 | 2005 |
| Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) ML Barreca, A Carotti, A Carrieri, A Chimirri, AM Monforte, MP Calace, ... Bioorganic & medicinal chemistry 7 (11), 2283-2292, 1999 | 88 | 1999 |
| A highly intensified ART regimen induces long-term viral suppression and restriction of the viral reservoir in a simian AIDS model IL Shytaj, S Norelli, B Chirullo, A Della Corte, M Collins, J Yalley-Ogunro, ... PLoS pathogens 8 (6), e1002774, 2012 | 87 | 2012 |
| Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor L De Luca, S Ferro, R Gitto, ML Barreca, S Agnello, F Christ, Z Debyser, ... Bioorganic & medicinal chemistry 18 (21), 7515-7521, 2010 | 81 | 2010 |
| Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT ML Barreca, A Rao, L De Luca, M Zappala, AM Monforte, G Maga, ... Journal of medicinal chemistry 48 (9), 3433-3437, 2005 | 80 | 2005 |
| Induced‐fit docking approach provides insight into the binding mode and mechanism of action of HIV‐1 integrase inhibitors ML Barreca, N Iraci, L De Luca, A Chimirri ChemMedChem: Chemistry Enabling Drug Discovery 4 (9), 1446-1456, 2009 | 76 | 2009 |
| Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors A Astolfi, T Felicetti, N Iraci, G Manfroni, S Massari, D Pietrella, O Tabarrini, ... Journal of medicinal chemistry 60 (4), 1598-1604, 2017 | 71 | 2017 |
| Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking L De Luca, A Pedretti, G Vistoli, ML Barreca, L Villa, P Monforte, A Chimirri Biochemical and Biophysical Research Communications 310 (4), 1083-1088, 2003 | 70 | 2003 |
| Efficient 3D database screening for novel HIV-1 IN inhibitors ML Barreca, A Rao, L De Luca, M Zappalà, C Gurnari, P Monforte, ... Journal of chemical information and computer sciences 44 (4), 1450-1455, 2004 | 65 | 2004 |
